je.st
news
MolMed TK Asco New Data from the Pivotal Phase III Randomized Trial TK008
2014-06-09 23:22:58| Logistics - Topix.net
Presented at ASCO data on the first set of patients from the pivotal Phase III TK008 study: the survival benefit exceeds trial target in acute leukaemia patients Milano June 9, 2014 - MolMed S.p.A. provided at the 50th ASCO annual meeting new data from the ongoing randomised pivotal Phase III study on its cell therapy product TK for high-risk acute ... (more)
Tags: data
iii
trial
phase
Category:Transportation and Logistics
Latest from this category |
All news |
||||||||||||||||||
|